Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists

Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists

US Patent 8642661 · Granted Feb 4, 2014

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or ty2021
Method of treating pain in elderly patients with mild renal impairment2021
Compositions and methods of using modified release solabegron for lower urinary 2020
Pharmaceutical compositions and the treatment of overactive bladder2020
Pharmaceutical compositions and the treatment of overactive bladder2020
Pharmaceutical compositions and the treatment of overactive bladder2020
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or ty2019
Pharmaceutical compositions and the treatment of overactive bladder2019
Pharmaceutical compositions and the treatment of overactive bladder2019
Pharmaceutical compositions and the treatment of overactive bladder2019
Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, o2018
Compositions and methods of using modified release solabegron for lower urinary 2018